VAN STRUM & TOWNE INC.

Position in NVS — Novartis AG

CIK 1080173 SAN FRANCISCO, CA

Position in NVS

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$383,493

+$21,170 QoQ

Shares Held

2,447

+3.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#1,007

of 1,603 holders

Holding Since

Jun 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VAN STRUM & TOWNE INC. holds $44,052,208 across 8 Drug Manufacturers - General names. NVS ranks #8 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	44,632	$11,335,189
2	AMGN	Amgen Inc	31,250	$11,316,250
3	ABBV	AbbVie Inc.	37,773	$9,505,197
4	LLY	ELI LILLY & Co	5,679	$6,811,563
5	PFE	Pfizer Inc	85,044	$2,047,859
6	MRK	Merck & Co., Inc.	13,293	$1,708,150
7	BMY	Bristol Myers Squibb Co	16,392	$944,507
8	NVS	Novartis AG This page	2,447	$383,493

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$383,493	2,447	+3.2%	Shares	Sole	2026-08-03
2026-03-31	$362,323	2,372	0.0%	Shares	Sole	2026-05-07
2025-12-31	$327,027	2,372	0.0%	Shares	Sole	2026-02-03
2025-09-30	$304,185	2,372	0.0%	Shares	Sole	2025-10-31
2025-06-30	$287,035	2,372	0.0%	Shares	Sole	2025-07-25
2025-03-31	$264,430	2,372	0.0%	Shares	Sole	2025-05-06
2024-12-31	$230,819	2,372	+20.3%	Shares	Sole	2025-02-10
2024-09-30	$226,819	1,972	0.0%	Shares	Sole	2024-11-12
2024-06-30	$209,939	1,972	0.0%	Shares	Sole	2024-07-25
2023-09-30	$200,867	1,972	-18.2%	Shares	Sole	2023-11-08
2021-12-31	$210,977	2,412	-7.7%	Shares	Sole	2022-02-08
2021-09-30	$213,609	2,612	0.0%	Shares	Sole	2021-11-12
2021-06-30	$238,318	2,612	+16.6%	Shares	Sole	2021-08-06
2020-12-31	$211,523	2,240	-4.5%	Shares	Sole	2021-02-03
2020-09-30	$203,921	2,345	0.0%	Shares	Sole	2020-11-12
2020-06-30	$204,812	2,345	—	Shares	Sole	2020-07-14
No filing history on record for this holder in this stock.